IRMD - Iradimed Co - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IRMD is currently covered by 2 analysts with an average price target of $120. This is a potential upside of $34.65 (40.6%) from yesterday's end of day stock price of $85.35.

Iradimed Co's activity chart (see below) currently has 33 price targets and 23 ratings on display. The stock rating distribution of IRMD is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 93.06% with an average time for these price targets to be met of 318.5 days.

Highest price target for IRMD is $120, Lowest price target is $120, average price target is $120.

Most recent stock forecast was given by JASON WITTES from ROTH MKM on 10-Feb-2026. First documented stock forecast 05-Oct-2016.

Best performing analysts who are covering IRMD - Iradimed Co:

Jason Wittes Frank Takkinen Scott Henry Chris Lewis

Currently out of the existing stock ratings of IRMD, 2 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 22-Apr-2024

$120

$34.65 (40.60%)

$72

9 months 5 days ago
(10-Feb-2026)

3/4 (75%)

$15.53 (14.87%)

283

Buy Since 12-Apr-2023

$120

$34.65 (40.60%)

$100

9 months 5 days ago
(10-Feb-2026)

5/6 (83.33%)

$15.53 (14.87%)

355

Buy Since 31-Oct-2017

$55

$-30.35 (-35.56%)

$48

3 years 3 months 8 days ago
(07-Aug-2023)

9/9 (100%)

$6.95 (14.46%)

224

Buy Since 05-Oct-2016

$12

$-73.35 (-85.94%)

$11.5

9 years 3 months 15 days ago
(31-Jul-2017)

3/3 (100%)

$3.05 (34.08%)

342

Show more analysts

Please expand the browser size to see the chart

What is IRMD (Iradimed Co) average time for price targets to be met?

On average it took 319 days for the stock forecasts to be reached, with an average price target met ratio of 93.06%.

Which analyst most recently updated their price target on IRMD (Iradimed Co)?

Jason Wittes

Which analyst has the current lower performing score on IRMD (Iradimed Co) with a proven track record?

CHRIS LEWIS

Which analyst has the most public recommendations on IRMD (Iradimed Co)?

Jason Wittes has 11 price targets and 9 ratings on IRMD

Which analyst is the currently most bullish on IRMD (Iradimed Co)?

Frank Takkinen with the highest potential upside of $34.65

Which analyst is the currently most reserved on IRMD (Iradimed Co)?

Chris Lewis with the lowest potential downside of -$73.35
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?